HEOR & market access
At Aixial Group, our HEOR & Market Access experts help sponsors generate meaningful evidence, navigate complex payer environments, and build strategies that maximise patient access to innovative healthcare solutions.
Demonstrating value beyond clinical evidence
Bringing an innovative therapy to market requires more than proving its safety and efficacy. Healthcare decision-makers increasingly expect robust evidence demonstrating clinical, economic, and patient value to support reimbursement and market access decisions.
Supporting access to innovation
Healthcare systems worldwide face increasing pressure to balance innovation, affordability, and patient outcomes. Payers are demanding stronger evidence to support funding decisions, while sponsors must demonstrate the real-world value of increasingly complex therapies.
From orphan drugs and oncology treatments to advanced therapies and precision medicine, HEOR and Market Access have become essential components of successful product development strategies. Our experts help sponsors anticipate challenges, generate relevant evidence, and communicate product value effectively to key decision-makers.
Our expertise
Health economics
Cost-effectiveness analysis
Cost-utility analysis
Budget impact modelling
Burden of illness studies
Economic evaluation strategies
Health technology assessment (HTA) support
Outcomes research
Patient-reported outcomes (PROs)
Quality of Life (QoL) assessments
Observational study design
Real-World Evidence (RWE) generation
Evidence gap analysis
Clinical and economic outcomes evaluation
Market access strategy
Early market access planning
Pricing and reimbursement strategy
Value proposition development
Stakeholder mapping
Payer evidence requirements assessment
Market landscape analysis
Health technology assessment (HTA)
HTA dossier preparation
Evidence generation planning
Comparative effectiveness assessments
Literature reviews
Value communication strategies
Looking for a HEOR & market access expertise ?
Turning evidence into patient access
At Aixial, our mission goes beyond clinical development. We help transform evidence into access and innovation into patient benefit.
By combining HEOR expertise, market access strategy, and deep clinical development knowledge, we support sponsors in making informed decisions, accelerating market adoption, and ensuring innovative therapies reach the patients who need them most.
Tailored collaboration models
Functional service provision
We have extensive experience in governance, management, and partnership as an FSP provider. Our approach is tailored to your requirements and adapts as the partnership evolves.
Consulting support
We provide the preclinical development capabilities and integrated consulting expertise needed to streamline development at every step, in a faster and more cost-effective way.
Q&A
Why is HEOR important in drug development?
HEOR helps pharmaceutical and biotech companies demonstrate the value of their products beyond clinical efficacy and safety. It supports reimbursement submissions, pricing strategies, market access activities, and informed healthcare decision-making.
At what stage of development should HEOR activities begin?
HEOR should be integrated as early as possible in the product development process. Early planning helps identify evidence needs, optimize clinical development programs, and build a strong value proposition for future reimbursement and market access success.
How does HEOR support Market Access?
HEOR provides the evidence required to demonstrate the clinical and economic value of a therapy. Through health economic models, real-world evidence, patient-reported outcomes, and burden-of-illness studies, HEOR strengthens market access and reimbursement applications.
What operational models do you offer ?
To match your internal infrastructure and budget, we offer three flexible delivery models:
Functional Service Provision (FSP): Dedicated experts seamlessly integrated into your teams.
Consulting & operational support: Ad-hoc expert guidance, data entry management, and clinical site training.
Why choose Aixial for HEOR & Market Access consulting?
Aixial combines scientific expertise, strategic insight, and operational excellence to help clients generate robust evidence, maximize product value, and accelerate patient access across global healthcare markets.
How can we support your next project?
Whether you’re looking for a protocol review or a proposal,
simply reach out to us by filling our request for proposal.
